News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ALK-Abello A/S Release: FDA Postpones Advisory Committee Meeting for Grass AIT Tablet Due to US Government Shutdown


10/8/2013 9:56:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALK (ALK-B.CO / OMX:ALK B / AKABY / AKBLF) today announced that due to the US government shutdown, the US Food and Drug Administration (FDA) has temporarily postponed the Allergenic Products Advisory Committee meeting scheduled for 6 November 2013 to discuss the Biologic License Application (BLA) for the investigational grass allergy immunotherapy (AIT) tablet. The FDA has not yet confirmed a new date for the Advisory Committee meeting. ALK will provide an update when additional information becomes available. - See more at: http://www.globenewswire.com/news-release/2013/10/08/578902/0/en/FDA-postpones-Advisory-Committee-meeting-for-grass-AIT-tablet-due-to-US-government-shutdown.html#sthash.wjCSNgaY.dpuf

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES